Defeating metastatic prostate cancer: Taubman Scholar posts new findings
The primary treatment for advanced or aggressive prostate cancer is to chemically or surgically short-circuit the body’s production of male hormones — called androgens — which drive the growth of the cancer cells. After a few years, however, the cancer invariably becomes resistant to this treatment, at which point it resumes its deadly progression. Now,…